Flaraxin Questions and answers
Professor, DMS A.V.Artyemov answers the questions
(Filatov Institute of eye diseases and tissue therapy AMS of Ukraine, Department of Oncology)
1. What is Flaraxin?
Flaraxin as a powerful specific and anti-tumoral interferonogenic medicine of vegetarian origin that is produced by unique technology. The acting substance of the medicine consists of vegetarian polyphenol compounds.
Flaraxin is a lyophilized powder of yellow-brown color, well dissolved in 5% glucose solution, physiological solution and water.
2. Is Flaraxin administered for?
Flaraxin is applicable for all clinic-morphological forms of malignant neoplasms, on all stages of tumoral process, non-malignant neoplasms, under viral, inflectional diseases, accompanied with development of secondary immunodeficiency, inertial viral infections of CNS, diseases, characterized by the development of autoimmune aggression.
3. What is known about mechanism of Flaraxin action?
Flaraxin has strictly expressed specific activity to oncological proteins in organism, causes micro-denatured changes in tumoral cells that causing their death with further elimination. Besides specific anti-tumoral effect of Flaraxin has an ability to activate production of endogenous interferon and the tumoral necrosis factor (TNF) in organism, F. able to support interferon high concentration during 72 hours after injection. This phenomenon provides wide participation of the immune system in the fight against tumoral structures.
4. What advantages has Flaraxin in comparison with traditional methods of treatment applied in oncology?
Known treatment methods of oncological patients (chemotherapeutic, radiothrapy and surgical) that are accompanied by high immune suppression, closing vicious circle of tumoral process.
The chemotherapy are using medicines, that have a number of reactionally-capable groupings and able to denaturate normal proteins (normal cells) with oncological protein groups, that explains it’s high toxicity for all body.
Flaraxin associated only with tumoral cells (proteins), causing their death and it does not have influence on hematogenesis, on respiratory organs, on excretory and digestive systems, on CNS, on skin and others. Flaraxin is powerful immunomodulator that does not suppress immune system but vice versa raises its level of functional activity.
5. Can Flaraxin be used in patients with exposed allergy, bronchial asthma?
Yes. Flaraxin able to associate and withdraw from the body the circulating immune complexes (CIC). Plasmapheresis is comparable with the ability of Flaraxin to remove CIC out of the body. The application of Flaraxin in patients that are suffering with allergic diseases, bronchial asthma essentially improves the state of patients in this category.
6. What is the advantage of FLARAXIN in treatment of infectious diseases in comparison with interferon groups?
The injections of interferon (including those received by recombination) can give good clinical effect. But this therapy is passive, substitutive, that is giving already prepared interferon and as result the production of own interferon by the body will be reduced. Developed countries starts to use medicines that are able to stimulate production of endogen (personal) interferon and it’s essentially have influence on price of treatment methods as well as their effectiveness. Flaraxin is well combined with other preparations (antibiotics, sulfanilamides) and can be used in mono- and complex therapy.
7. What kind of doses, ways and methods of treatment by Flaraxin exists?
Flaraxin is produced in tree medical forms: а)lyophilized powder for intravenous injections 150 and 75 mg in glass bottles; b) Cones with flaraxin for rectal and vaginal application with 75mg of active substance c) Tablets and Capsules with Flaraxin for oral application with 75mg and 150mg of active substance.
The application of Flaraxin in the dose 2 mg/kg for the patient is clinically confirmed. Whereas of absolute Flaraxin non-toxicity the twice- or thrice rising of the dosage does not have negative influence on the body.
Normally Flaraxin is administered as 16 intravenous infusions for one course of the treatment. The injections of the Flaraxin can be done persistently (16 days, one injection a day) with 10-14 days break between the courses or it can be done by two half-courses each 8 days and than week break and again half-course 8 days by one injection a day. The break between the full treatment courses should be 10-14 days.
It can be applicable with Cones, Capsules and tablets of Flaraxin rectally, vaginally or orally with aim to have local influence on tumors. The application of Cones is clinically justified under insufficiently exposed venous net or phlebitis, developed as a result of chemotherapy application.
8. What are side effects can be expected during Flaraxin application?
During application of Flaraxin the allergic reaction can be marked very seldom, mainly it’s related with individual intolerance to iodine containing medicines. During treatment of oncological patients the light pain can appear in the main place of tumoral nod or metastases, more rarely the rise of body temperature up to subfebrile indices can be marked (37,0 – 38,5°С) as a response reaction of the organism on entering of tumoral cells decay products into the blood.
Take in to account possibility of Support from our medical staff on cancer treatment with Flaraxin and additional treatment recommendations.
Stccc Phoenix is looking for doctors and medical centers around the world to work together ,to bring cancer into absolute remission ?
You can contact us: Contact information
